Biomarkers for atypical Parkinsonism: Some progress, but much work remains
Authors:
- 1 March 2018
- journal article
- editorial
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 48, 1-2
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Recommendations of the Global Multiple System Atrophy Research Roadmap MeetingNeurology, 2018
- 18F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter studyAnnals of Neurology, 2017
- Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approachesThe Lancet Neurology, 2017
- APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsyNeurology, 2003